Applications Published 6 March 2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Aqueous carrier systems for lipophilic ingredients
L'Oreal 1183008*
Acidic buffered nasal spray
Wisconsin Alumni Research Foundation 1183009*
Implantable gel compsns and method of manufacture
Alza Corp 1183010*
Method of treating angina and/or anginal equivalents, and pharmaceutical compsns and kit related thereto
Esperion Mergerco 1183011*
Novel formulations comprising lipid-regulating agents
Abbott Laboratories 1183012*
Melt granulation
Lek Tovarna Farmacevtskih Kemicnih Izdelkov 1183013*
Controlled release and taste masking oral pharmaceutical formulations
Cosmo 1183014*
Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
Gruenenthal 1183015*
Sterocomplex hydrogels
Universiteit Utrecht 1183016*
Novel formulations comprising lipid-regulating agents
Abbott Laboratories 1183018*
Methods for coating particles and particles produced thereby
Nanosphere 1183018*
ACE-2 inhibiting compound and methods of use thereof
Millennium Pharmaceuticals 1183019*
Use of (-)-(3-trihalomethylpehnoxy)(4-halophenyl)acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
Metabolex; Diatex 1183020*
Stimulating transport of glucose into animal tissue by the administration of pinitol
Humanetics Corp 1183021*
Method and compsn for treatment of mammalian nasal and sinus diseases caused by inflammatory response
Cellular Sciences 1183022*
Use of verampamil and verampamil derivatives for producing medicaments with an inhibiting effect on beta-glucuronidase in human tissue
PAZ Arzneimittel 1183023*
Therapeutic use of melatonin
Neurim Pharmaceuticals 1183024*
Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
Neurosearch 1183025*
Improved pharmaceutical formulations
Abbott Laboratories 1183026*
Pharmaceutical formulations and methods comprising intranasal morphine
Nastech Pharmaceutical 1182027*
New use of macrolide compounds for inducing chondrogenic differentiation
Fujisawa Pharmaceutical 1183028*
Pharmaceutical preparation containing the active substance diamorphine and its utilisation in a method for treating opiate addiction
LTS Lohmann Therapie-Systeme 1183029*
Methods of making and using N-desmethylzopicline
Sepracor 1183030*
Quinoxaline containing medicaments for post-exposure prophylaxis of an HIV infection
The Japanese National Institute of Infectious Diseases; Mori, Kazayasu; Yasutomi, Yashiro; Sugama, Kazushige; Sawada, Shuzo; Ruebsamen-Waigman, Helga 1183031*
Method of enhancing insulin action
Cell Therapeutics 1183032*
Pyrrolotriazine inhibitors of kinases
Bristol-Myers Squibb 1183033*
Modulators of methylation for control of bacterial virulence
Anticancer 1183034*
Bone marrow transplantation for treatment of stroke
Henry Ford Health System 1183035*
Method for preparing dual virally inactivated immune globulin for intravenous administration
Alpha Therapeutic Corp 1183036*
Methods and compsns for modulating immune response and for the treatment of inflammatory disease
Foodscience 1183037*
Plant preparation containing phenethylisothiocyanate
Rutgers, the State University of New Jersey 1183038*
Pharmaceutical preparations of bioactive substances extracted from natural sources
Armadillo Pharmaceuticals 1183039*
Therapeutic use of an inhibitor of a hedgehog-related signalling pathway
Lornatis 1183040*
Ligand for CD7, and methods for use thereof
Immunex Corp 1183041*
Methods for treating diabetes
Celtrix Pharmaceuticals 1182042*
Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors
Bio & Bio Licensing 1183043*
Adjuvant combinations for immunisation and vaccines
Statens Serum Institut 1183044*
Stability, biocompatibility optimised adjuvant (SBA) for enhancing humoral and cellular immune response
Pharmasol 1183045*
Aminotetralin derivative for the therapy of cardiovascular disease
Chiesi Farmaceutici 1183046*
Pharmaceutical preparation
Bitop; Barth, Stefan 1183047*
Bradykinin receptor antagonists
Novartis 1183233*
Inhibitors of Factor XA
Cor Therapeutics 1183234*
Novel antioxidants, preparation method and uses
Centre National de la Recherche Scientifique 1183237*
Metabolic glutamate receptor antagonists
Eli Lilly 1183238*
Aromatic sulphone hydroxamic acid metalloprotease inhibitor
GD Searle 1183239*
Beta2-adrenoreceptor agonists
Novartis 1183240*
Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
Aventis Pharma Deutschland 1183241*
Short-acting benzodiazepines
Glaxo Group 1183243*
Tetrazolinone derivatives
Nihon Bayer Agrochem 1183246*
Polycyclic thiazole systems and their utilisation as anorectics
Aventis Pharma 1183247*
Semi-synthesis of paclitaxel using dialkyldichlorosilanes
Bristol-Myers Squibb 1183250*
Indolylpiperidine derivatives an antihistaminic and antiallergic agents
Almirall Prodesfarma 1183251*
New pharmaceutically active compounds
AstraZeneca 1183252*
C7 ester substituted taxanes as antitumour agents
Florida State University 1183253*